Not available
Quote | InspireMD Inc. (NYSE:NSPR)
Last: | $5.4297 |
---|---|
Change Percent: | 0.18% |
Open: | $5.49 |
Close: | $5.4297 |
High: | $5.55 |
Low: | $5.32 |
Volume: | 132,772 |
Last Trade Date Time: | 06/08/2021 12:54:35 am |
News | InspireMD Inc. (NYSE:NSPR)
TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentati...
TEL AVIV, Israel and MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that an abstract of the one-year outcomes from its C-GUARDIANS IDE clinical trial of t...
Message Board Posts | InspireMD Inc. (NYSE:NSPR)
Subject | By | Source | When |
---|---|---|---|
bears and bulls | Value_Investor | investorshub | 05/14/2023 5:20:14 PM |
$NSPR MomentumIts now last up | Disquisition | investorshub | 05/12/2023 8:59:56 PM |
The trading up | iluvkush | investorshub | 05/10/2023 4:00:25 PM |
Price trading last up | Disquisition | investorshub | 05/10/2023 2:10:52 AM |
Long and strong lets hope im right | Value_Investor | investorshub | 05/08/2023 2:48:36 AM |
News, Short Squeeze, Breakout and More Instantly...
TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentati...
TEL AVIV, Israel and MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that an abstract of the one-year outcomes from its C-GUARDIANS IDE clinical trial of t...